Wynne
Wynne Chan, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20160092173 | SEAMLESS RESTFUL API GENERATION AND CONSUMPTION THROUGH A SINGLE CHANNEL - Techniques are disclosed for enabling seamless RESTful API generation and consumption through a single channel. Certain techniques are disclosed that allow for clients to both create an API and then immediately use or consume the API through a single channel of communication with a single component, such as a series of HTTP requests and/or responses sent between an application and an API Generation and Consumption (AGC) module. | 03-31-2016 |
Wynne Hsu, Singapore SG
Patent application number | Description | Published |
---|---|---|
20110026789 | RETINAL IMAGE ANALYSIS SYSTEMS AND METHODS - A platform is proposed for automated analysis of retinal images, for obtaining from them information characterizing retinal blood vessels which may be useful in forming a diagnosis of a medical condition. A first aspect of the invention proposes that a plurality of characteristics of the retina are extracted, in order to provide data which is useful for enabling an evaluation of cardiovascular risk prediction, or even diagnosis of a cardiovascular condition. A second aspect uses fractal analysis of retinal images to provide vascular disease risk prediction, such as, but not limited to, diabetes and hypertension. | 02-03-2011 |
Wynne Jones, Canterbury GB
Patent application number | Description | Published |
---|---|---|
20100105091 | Method for Measuring the Concentration of Transient Proteolytic Activity in Composite Biological Media Containing Cells - A method is provided for determining in real time the course of thrombin activity in a sample of clotting blood or plasma as it appears in and disappears from the sample which comprises adding a signal substrate to said sample, said signal substrate causing a detectable signal related to the amount of conversion product formed upon reaction by the generated proteolytic activity, monitoring the signal development in time in said sample to provide a curve, and mixing said sample frequently so that clot formation occurs in a dense manner such that the majority of the sample remains fluid and that cell precipitation is inhibited, wherein said monitoring and mixing steps are repeated and performed in an alternate way. | 04-29-2010 |
Wynne Weston-Davies, Cheltenham GB
Patent application number | Description | Published |
---|---|---|
20150196619 | EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT - The present invention relates to methods of treating and preventing the inflammatory effects of viral infection of the upper and lower respiratory tracts, including infection by SARS coronovirus (SARS), pandemic Influenza A H5N1 (avian influenza) and pandemic influenza A H1N1 (swine 'flu). | 07-16-2015 |
Wynne Weston-Davies, London GB
Patent application number | Description | Published |
---|---|---|
20110152171 | HISTAMINE BINDING PROTEIN - The invention relates to histamine binding proteins. The invention also relates to the use of such histamine binding proteins in the treatment and prevention of diseases. | 06-23-2011 |
Wynne Weston-Davies, Reading Berkshire GB
Patent application number | Description | Published |
---|---|---|
20090209459 | Method of Treating Myasthenia Gravis - The invention relates to the use of agents that bind the complement protein C5 in the treatment of diseases associated with inappropriate complement activation and in particular in the treatment of myasthenia gravis. | 08-20-2009 |
Wynne Weston-Davies, Salperton GB
Patent application number | Description | Published |
---|---|---|
20120283167 | EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT - The present invention relates to methods of treating and preventing the inflammatory effects of viral infection of the upper and lower respiratory tracts, including infection by SARS coronovirus (SARS), pandemic Influenza A H5N1 (avian influenza) and pandemic influenza A H1N1 (swine 'flu). | 11-08-2012 |